Archer Investment Corp Biogen Inc. Transaction History

Archer Investment Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $268,704 - $345,324	-1,200 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $259,000 - $414,710	-1,000 Reduced 45.45%	1,200 $416 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $41,058 - $48,102	-169 Reduced 7.13%	2,200 $615 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $64,868 - $74,898	245 Added 11.53%	2,369 $672 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $9,311 - $12,331	-36 Reduced 1.67%	2,124 $568,000
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $43,016 - $54,566	160 Added 8.0%	2,160 $683,000
Q4 2019 Feb 20, 2020	BUY	$220.06 - $304.07 $368,380 - $509,013	1,674 Added 513.5%	2,000 $593,000
Q3 2019 Apr 01, 2020	BUY	$217.44 - $243.88 $5,653 - $6,340	26 Added 8.67%	326 $76,000
Q4 2018 Apr 06, 2020	BUY	$278.5 - $352.75 $83,550 - $105,825	300 New	300 $90,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Archer Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Archer Investment Corp with notifications on news.